|
|
Apollomics Inc Wt
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 10/28/2026 11:13
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization31.22 mln
Float223 mln
Earnings Date12/22/2026
Pre-Tax Margin
-129%
Severely loss-making
Key Fundamentals
EPS-4.34
ROE-1,305
RPS20.19
ROIC-538
ROA-106
Interest Cover-146
EBITDA, mln-387
EV / EBITDA-0.05
EV / EBIT-0.05
Revenue, mln8.50
Quote Details
Last
0.0102
Change
-0.0002 (-1.92%)
Open
0.0103
Volume
3,850
Turnover
39.27
Average Volume
15,463
Financial Ratios
Pre-Tax Profit Margin-129
Current Ratio0.96
Price / Book0.56
Price / Tangible Book0.56
Price / Sales3.22
Financial Strength
Altman Z-Score-148
Piotroski F-Score
4
/ 9
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
0.99% |
70
/ 100
 |
| 1 Month |
-14.93% |
22
/ 100
 |
| 2 Months |
-39.64% |
12
/ 100
 |
| 6 Months |
-36.25% |
18
/ 100
 |
| 1 Year |
-66% |
14
/ 100
|
|
| |
